2022-501694-39-01RecruitingPhase 1/2
mFBG PET-CT for neuroblastoma
A Prospective Study Comparing [18F]mFBG PET-CT to [123I]mIBG Scanning in Neuroblastoma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To compare the diagnostic performance of [18F]mFBG PET-CT to conventional [123I]mIBG SPECT-CT for the detection of skeletal lesions in patients with neuroblastoma
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- First submitted
- 27 Jun 2024
- Start date
- 12 Nov 2024
- Lead sponsor
- Princess Maxima Center For Pediatric Oncology
- Diseases
- Childhood cancers, Neuroblastoma
- EU CT number
- 2022-501694-39-01
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 58
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other
- [18F]mFBG imaging cannot be scheduled within two weeks of [123I]mIBG imaging
- Pregnancy of patient
Who the study is looking for
- Patient with (a clinical suspicion of) neuroblastoma who is referred for conventional [123I]mIBG imaging
- Written informed consent from patients and/or from parents or legal guardians, according to local law and regulations
Age in the registry: - to 64 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Princess Máxima Center for Pediatric Oncology | Utrecht | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.